MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways

Oncogene

Volumn 31, Issue 36, 2012, Pages 4067-4075

  Qin, W ^a   Dong, P ^a   Ma, C ^b   Mitchelson, K ^a,c   Deng, T ^a,c   Zhang, L ^c   Sun, Y ^c   Feng, X ^d   Ding, Y ^b   Lu, X ^b   He, J ^e   Wen, H ^b   Cheng, J ^a,c  

^a Tsinghua University   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

^e CANCER HOSPITAL   (China)

Author keywords

cervical carcinoma; miR 133b; signal pathways; tumorigenesis and metastasis

Indexed keywords

MICRORNA; MICRORNA 133B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; PROTEIN CDC42; PROTEIN KINASE B; PROTEIN MST2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LATENT PERIOD; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; UTERINE CERVIX CARCINOMA;

ANIMALS; BASE SEQUENCE; CARCINOMA; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; MICRORNAS; NEOPLASM TRANSPLANTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

MAMMALIA;

EID: 84866124741     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.561     Document Type: Article

References (40)

1. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. (2003). ERK(-MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63: 1684-1695.
2. Bertelsen BI, Steine SJ, Sandvei R, Molven A, Laerum OD. (2006). Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphoryla-tion. Int J Cancer 118: 1877-1883.
3. Burk RD. (1999). Pernicious papillomavirus infection. N Engl J Med 341: 1687-1688.
4. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
5. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. (2005). The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24: 2076-2086.
6. Cifone MA, Fidler IJ. (1980). Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA 77: 1039-1043.
7. Cinar B, Fang PK, Lutchman M, Di Vizio D, Adam RM, Pavlova N et al. (2007). The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J 26: 4523-4534.
8. Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, Marsh CB et al. (2009). MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun 388: 483-489.
9. Dhillon AS, Hagan S, Rath O, Kolch W. (2007). MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
10. Garzon R, Calin GA, Croce CM. (2009). MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
11. Good M, Lavin M, Chen P, Kidson C. (1978). Dependence on cloning method of survival of human melanoma cells after ultraviolet and ionizing radiation. Cancer Res 38: 4671-4675.
12. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L et al. (2011). MicroRNAs-372/373 promote the expression of hepatitis B Virus through the targeting of nuclear factor I/B. Hepatology 54: 808-819.
13. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X et al. (2008). Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68: 26-33.
14. He L, Hannon GJ. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
15. Hu G, Chen D, Li X, Yang K, Wang H, Wu W. (2010). MiR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 10: 190-197.
16. Kahn JA. (2009). HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med 361: 271-278.
17. Kohrenhagen N, Voelker HU, Schmidt M, Kapp M, Krockenberger M, Frambach T et al. (2008). Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia. J Obstet Gynaecol Res 34: 293-300.
18. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
19. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY et al. (2008). Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542.
20. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
21. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. (2003). Prediction of mammalian microRNA targets. Cell 115: 787-798.
22. Li Z, Dong X, Wang Z, Liu W, Deng N, Ding Y et al. (2005). Regulation of PTEN by Rho small GTPases. Nat Cell Biol 7: 399-404.
23. Liu X, Chen Z, Yu J, Xia J, Zhou X. (2009). MicroRNA profiling and head and neck cancer. Comp Funct Genomics: 2009: 837514.
24. Mendell JT. (2008). MiRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
25. Mumby M. (2007). PP2A: unveiling a reluctant tumor suppressor. Cell 130: 21-24.
26. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
27. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. (2006). Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci USA 103: 8721-8726.
28. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. (1994). HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57.
29. Schiffman M, Castle PE. (2005). The promise of global cervical-cancer prevention. N Engl J Med 353: 2101-2104.
30. Shibue T, Weinberg RA. (2009). Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106: 10290-10295.
31. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401.
32. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L et al. (2010). Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 107: 1431-1436.
33. Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C et al. (2011). A five-microRNA signature for squamous cell lung carcinoma (SCC) diagnosis and hsa-miR-31 for SCC prognosis. Clin Cancer Res 17: 6802-6811.
34. Testa JR, Bellacosa A. (2001). AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98: 10983-10985.
35. Tusher VG, Tibshirani R, Chu G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
36. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP et al. (2008). MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 1223-1232.
37. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C et al. (2008). Aberrant expression of oncogenic and tumor-suppressive micro-RNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
38. Watanabe T, Takeda A, Mise K, Okuno T, Suzuki T, Minami N et al. (2005). Stage-specific expression of microRNAs during Xenopus development. FEBS Lett 579: 318-324.
39. Wong TS, Liu XB, Chung-Wai Ho A, Po-Wing Yuen A, Wai-Man Ng R, Ignace Wei W. (2008). Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 123: 251-257.
40. zur Hausen H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.